Insider trades
O'Neill Gilmore Neil, CEO of Editas Medicine EDIT, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $64.5K. The latest trade was on 06/03.
O'Neill Gilmore Neil
CEO
- Company
- Editas Medicine EDIT
- First filing
- 23/03/06
- Trades
- 22 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$64.5K
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Editas MedicineEDIT | Open-market sale10b5-1 plan | 06/03 | 06/05 | 15,380 sh | $2.70 | $41,526 | −5.8% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 03/03 | 03/04 | 5,394 sh | $2.02 | $10,895.88 | −2.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/12/03 | 25/12/04 | 5,603 sh | $2.15 | $12,046.45 | −2.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/09/03 | 25/09/04 | 5,592 sh | $2.60 | $14,539.2 | −2.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/06/03 | 25/06/04 | 15,192 sh | $1.72 | $26,130.24 | −5.1% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/03/04 | 25/03/05 | 16,632 sh | $1.71 | $28,440.72 | −5.3% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 24/12/03 | 24/12/05 | 1,618 sh | $2.08 | $3,365.44 | −0.5% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 24/09/04 | 24/09/06 | 1,555 sh | $3.42 | $5,318.1 | −0.5% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 24/06/04 | 24/06/06 | 12,191 sh | $5.50 | $67,050.5 | −3.7% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 24/03/05 | 24/03/05 | 77,824 sh | $9.42 | $733,102.08 | −19.2% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 23/06/05 | 23/06/07 | 6,486 sh | $9.50 | $61,617 | −4.7% |